AGENDA

Relaxed networking reception to Kick off the MTI25

An evening reception with drinks and canapés, providing ample opportunity for all attendees to network prior the event, foster collaborations, and build lasting relationships in a relaxed setting.

Entry requires premium access ticket.

Attendees arrive, network, and explore the Innovation Hub.
Opportunity for early 1:1 meetings.

Europe’s Ambition for Global MedTech Leadership

Outlining “Choose Europe for Life Sciences” strategic vision for health, medical technology, and biopharma by 2030, and its core pillas.

Vertical AI Infrastructure

Bridging the Evaluation Gap in Real-World Care

Focus discussion: Join AI developers and clinicians in a dynamic discussion about the transition to Vertical AI Infrastructure. As the EU AI Act takes full effect, we explore how medical devices are moving from simple data collection to providing interpretive judgment at the bedside.

Discover strategies for deploying explainable “digital coworkers” that support human expertise in high-acuity hospital environments, ensuring that advanced technology empowers the workforce and solves the real-world evaluation gap.

The FemTech Growth Frontier

Scaling Research to Global Assets

Focus Discussion: Explore the $100$ billion opportunity in women’s health in this broad session designed for investors and ecosystem leaders. We discuss shifting the narrative from reproductive niches to foundational economic pillars like menopause, cardio-precision, and longevity.

Learn how research is being transformed into global industrial assets through gender-disaggregated data. This discussion highlights the synergy needed between molecular research and scalable care models to attract gender-conscious capital and secure valuation protection in 2026.

Networking & Curated 1:1 Matchmaking

Curated matchmaking session facilitates pre-scheduled 1:1 meetings between pre-qualified innovators and strategic investors.

This high-impact block provides a dedicated platform to discuss M&A, financing, and licensing opportunities essential for moving deep-tech breakthroughs from the lab to global patient impact.

Accelerating Deep-Tech Solutions from Molecular Sensing to Clinical AI

Bridging the Translational Gap in Women’s Health and Longevity

This institutional showcase features high-potential ventures from EIC Pathfinder and Transition programs delivering disruptive breakthroughs in women’s health.

From liquid biopsy platforms for endometrial cancer and regenerative biomaterials for oncology-related reconstruction to AI-powered diagnostic engines for fertility triage, these ventures represent the next generation of clinical-grade assets.

The session focuses on de-risking deep-tech innovations, providing immediate diagnostic feedback from Series A investors to ensure scientific milestones align with the 2026 mandate for “Evidence Maturity.”

Matchmaking Lunch & Curated 1:1 Meetings 

Step into a relaxed setting designed to foster high-impact connections between pre-qualified innovators and strategic investors. This curated matchmaking facilitates pre-scheduled 1:1 meetings to discuss M&A, financing, and licensing opportunities.

Attendees can also engage to build the relationships required to bridge the translational gap. It is an essential moment to spark strategic partnerships while the morning’s industry insights are still fresh. 

Held in a private room parallel to the lunch.

Exclusive session convenes leading partners to discuss capital allocation in the women’s health growth frontier.

Participants will evaluate the latest clinical proof points and multi-hormone modeling data to identify high-yield investment opportunities.

This closed-door setting fosters candid exchange on de-risking deep-science ventures and orchestrating the ecosystem synergy required for market capture.

Capital Velocity

Mastering the 2026 European HealthTech Investment Cycle

Master the evolving investment landscape in this high-velocity session designed for strategic deal-makers. We navigate the 2026 “Dry Powder Paradox,” exploring why nearly $2.5$ trillion remains unallocated despite a surge in innovation.

Gain tactical insights into the rise of industrial maturity and profitable efficiency, where clinical validation acts as the primary determinant of asset value. This is your essential playbook for securing capital and mastering the current European health-tech investment cycle.

Translating European Deep-Tech into Scalable Assets

Bridging the Translational Gap from Scientific Design to Industrial Assets.

Discover the next wave of European breakthroughs in this institutional showcase featuring high-potential ventures from EIC Pathfinder to Acceleration programs.

From advanced surgical robotics to autonomous diagnostic tools, these innovations represent clinically validated data ready for commercial scaling. Investors will provide immediate diagnostic feedback to ensure scientific milestones align with the 2026 mandate for “Evidence Maturity.”

This is a high-yield opportunity to engage with the continent’s most disruptive deep-tech assets in a conversational environment.

The 2027 MedTech Roadmap

From Predictive Intelligence to Market Capture

Join us for a forward-looking exploration of the MedTech landscape moving toward 2027. We examine the transition from reactive data collection to Predictive Intelligence that reshapes clinical pathways and patient outcomes.

Discover how European leaders are orchestrating technology captures through strategic integration and data sovereignty. This session provides an essential roadmap for navigating the shift from single-point innovations to scalable, service-enabled ecosystems that secure long-term market dominance across the continent’s maturing health-tech systems.

The Energy Pulse Reset

Join us for a focused afternoon networking break designed to provide a quick reset before the final high-intensity sessions. This thirty-minute break offers a relaxed setting to continue morning conversations and forge new strategic connections with European partners.

Engage with fellow attendees over refreshments and explore the latest deep-tech demonstrations while capturing the essential insights required for a successful market capture in the 2026 European health-tech investment cycle. Refresh and reconnect before the finale.

Regulatory Darwinism

Survival of the Compliant in the 2026 Capital Race

In the 2026 capital race, compliance has become the ultimate differentiator for HealthTech investment. This session examines Regulatory Darwinism, where full enforcement of the EU AI Act and MDR creates a binary filter for deal-making.

Gain insights from institutional investors and regulatory architects on why capital is concentrating around ventures with robust “Compliance Moats.” Learn how to turn regulatory rigor into a strategic advantage that protects valuation and ensures long-term survival in the European Single Market. 

Digital Health & AI Innovations

Join us for this dynamic session to identify market-ready innovations poised to revolutionize European healthcare delivery and secure essential investment.

A pitching session open to a select number of innovative startups showcasing breakthroughs in digital health solutions, AI-powered diagnostics, virtual care platforms,nand health data analytics.

• Medical devices
• Digital health
• Biotech
• AI
• Robotics

Application-based selection process.

Innovation Excellence Awards & Closing Remarks

Join us for the grand finale as we announce the winners of the pitching competition and the European sector pioneer award. We celebrate the most disruptive innovators and recognize the achievements that have moved the needle for patient care in 2026.

This closing ceremony reflects on the day’s highlights and provides final remarks on the roadmap ahead, inviting all attendees to remain engaged in the ongoing mission to industrialize medical breakthroughs across the European continent. Celebrate sovereign innovation